findmyKOL
Clinical trialNCT03118518CompletedInterventional

STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation

SponsorMedtronic Cardiac Ablation SolutionsEnrollment225Atrial FibrillationAtrial Fibrillation New Onset
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To provide data demonstrating the safety and effectiveness of the Arctic Front Advance™ Cardiac CryoAblation Catheter for the treatment of recurrent symptomatic paroxysmal atrial fibrillation, without the requirement that the subjects be drug refractory.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Grandview Medical Center

    Birmingham, Alabama, United States

  • Alaska Heart Institute

    Anchorage, Alaska, United States

  • Hoag Hospital Newport Beach

    Newport Beach, California, United States

  • Medstar Washington Hospital Center

    Washington D.C., District of Columbia, United States

  • Tallahassee Research Institute Inc

    Tallahassee, Florida, United States

  • Baycare Medical Group Cardiology

    Tampa, Florida, United States

  • Wellstar Research Institute

    Marietta, Georgia, United States

  • Krannert Institute of Cardiology

    Indianapolis, Indiana, United States

  • Iowa Heart Center

    West Des Moines, Iowa, United States

  • Our Lady of the Lake Office of Research

    Baton Rouge, Louisiana, United States

  • Southcoast Health System

    New Bedford, Massachusetts, United States

  • University of Michigan Health System - University Hospital

    Ann Arbor, Michigan, United States

  • Spectrum Health Hospitals

    Grand Rapids, Michigan, United States

  • Healtheast Saint Josephs Hospital

    Saint Paul, Minnesota, United States

  • Bryan Heart

    Lincoln, Nebraska, United States

  • Hackensack University Medical Center

    Hackensack, New Jersey, United States

  • the Valley Hospital

    Ridgewood, New Jersey, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • Ohio State University

    Columbus, Ohio, United States

  • Integris Baptist Medical Center, Inc.

    Oklahoma City, Oklahoma, United States

  • Providence Saint Vincent Medical Center

    Portland, Oregon, United States

  • Lehigh Valley Health

    Allentown, Pennsylvania, United States

  • Geisinger Medical Center

    Danville, Pennsylvania, United States

  • Aurora Cardiovascular Services

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Antiarrhythmic drug
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 Jun 2017
Primary completion
25 Jun 2020
Completion
25 Jun 2020
Last update posted
13 Feb 2025
Registered enrollment
225
Registry id
NCT03118518
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.